Meet Our Team
Members of the Mount Sinai NeuroAids team include:
- David M. Simpson, MD, Director of the Clinical Neurophysiology Laboratories and Director of the NeuroAIDS Program at The Mount Sinai Hospital. Dr. Simpson is the principal investigator for many studies, including the treatment of spasticity with botulinum toxin, management of pain in patients with peripheral neuropathy, and the diagnosis and treatment of patients with neurological complications of HIV/AIDS.
Dr. Simpson sits on the editorial board of AIDS Patient Care and Current HIV/AIDS Reports. He is frequently listed among Castle Connolly’s Top Doctors in the New York Metro Area, New York Times Super Doctors, and New York magazine’s Best Doctors in New York. He lectures extensively internationally in his fields of expertise.
- Susan Morgello, MD, a professor of pathology and neuroscience and medically trained as a diagnostic neuropathologist. Dr. Morgello is the principal investigator of the Manhattan HIV Brain Bank — an observational study and research resource that provides clinical data and biospecimens to qualified investigators interested in HIV-associated nervous system disorders. Along with Dr. Simpson, Dr. Morgello is a principal investigator in the multicenter CNS HIV Antiretroviral Therapy Effects Research (CHARTER) consortium.
- Jessica Robinson-Papp, MD, a neurologist with special interest in neuropathy and the neurologic complications of HIV/AIDS. She is the recipient of a grant from the National Institute of Neurological Disorders and Stroke to study HIV-associated neuropathy. Dr. Robinson-Papp performs electromyography (EMG), autonomic testing, and evoked potentials to aid in the diagnosis of peripheral nervous system disorders. She also provides neurologic consultations at the Jack Martin Fund Clinic. Dr. Robinson-Papp is a lecturer for the Mount Sinai Institute for NeuroAIDS Disparities and the AIDS Education and Training Center.
- Kathryn J. Elliott, MD, an internationally trained neurologist with internal medicine training whose background includes fellowship and faculty experience in neuro-oncology, pain, and palliative care at Memorial Sloan-Kettering Cancer Center. Dr. Elliott specializes in neuropathic pain as well as infectious neurology and has a special interest in acute zoster and postherpetic neuralgia. Dr. Elliott is the neurologist for the Manhattan HIV Brain Bank and is principal investigator on two neuropathic pain studies.
- David Dorfman, PhD, who maintains a clinical practice as a neuropsychologist and psychologist, with a substantial part of his work involving patients with HIV-related issues. His research has predominantly concerned the neuropsychiatric and psychosocial complications of HIV infection. His current HIV research is related to pain and the interaction of HIV status and normal aging. Dr. Dorfman has been principal investigator on HIV-related studies supported by the National Institutes of Health (NIH), the American Foundation for Aids Research, the Aaron Diamond Foundation, the AIDS Community Research Initiative of America, and the Jacob & Valeria Langeloth Foundation.
- Mary Catherine George, MA, research program manager who began her work during the early years of the HIV epidemic. Ms. George oversees research and education involving the neurologic complications of HIV, post-stroke spasticity, and other research initiatives involving pain and behavior. Ms. George is pursuing a doctoral degree in health psychology with an interest in human behavior and how to address wellness and maintain health. Her areas of research interest involve stress, anxiety, pain management, and aging within the context of chronic illness, such as HIV.
David M. Simpson, MD
Director of NeuroAIDS Program
Jessica Robinson-Papp, MD
Kathryn J. Elliott, MD